Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2013 Feb 1.
Published in final edited form as: Semin Fetal Neonatal Med. 2011 Sep 25;17(1):12–19. doi: 10.1016/j.siny.2011.09.001

Intrauterine infection and preterm labor

Varkha Agrawal a, Emmet Hirsch a,b,*
PMCID: PMC3242863  NIHMSID: NIHMS328009  PMID: 21944863

Summary

Preterm labor is defined as labor that begins before 37 completed weeks of pregnancy. More than 12% of infants born in the USA are preterm. At least 40% of preterm births are associated with intrauterine infection. Toll-like receptors (TLRs) are members of a family of cell-surface proteins responsible for recognition of a diverse spectrum of bacterial, viral and fungal pathogens. TLRs initiate the host innate (i.e. non-adaptive) immune response, inducing a proinflammatory cascade involving cytokines, chemokines, prostaglandins, and other effector molecules that result in the characteristic phenomena of labor, such as uterine contractions and rupture of fetal membranes. These cascades may also be activated by mechanisms that are not primarily infectious but are accompanied by inflammatory responses. Now that the molecular mechanisms linking infection and labor have been, to a large extent, elucidated, the challenge is to identify points of overlap with non-infectious causes of labor and to find intervention strategies that can minimize the negative impact of preterm delivery.

Keywords: Chorioamnionitis, Cytokines, Preterm delivery, Preterm rupture of membranes, Toll-like receptor

[A]Introduction

Preterm labor is defined as labor that begins before 37 completed weeks of pregnancy. More than 12% of infants born in the USA are preterm.1 Preterm birth is the major cause of neonatal morbidity and mortality in developed countries. Sequelae of preterm birth are common in the neonatal period, may persist into adulthood and are inversely related to gestational age.

Preterm birth may result from either spontaneous developments or medically indicated interventions. Known causes of spontaneous preterm labor include infection (intrauterine or extrauterine), multiple gestation, placental abruption, hormonal disruptions and other factors,2 though a large proportion of preterm births are ‘idiopathic’, or without known cause.

At least 40% of preterm births are associated with intrauterine infection.3 In individual cases it is often difficult to determine whether infection is the cause or consequence of the processes leading to preterm delivery. However, there is abundant evidence that infection and the inflammation generated by infection, whether within the gestational tissues or elsewhere, are a primary cause of a substantial proportion of preterm births. This evidence includes the following: (a) the amniotic fluid of patients with preterm labor has higher rates of microbial colonization and levels of inflammatory cytokines than preterm patients not in labor and term patients in labor;4 (b) intrauterine or systemic administration of microbes or microbial products to pregnant animals can result in preterm labor and delivery;511 (c) extrauterine maternal infections such as pyelonephritis,12 pneumonia13 and periodontal disease14 have been associated with premature parturition; (d) subclinical intrauterine infections are associated with preterm labor and delivery;15 (e) patients with intra-amniotic infection16 or intrauterine inflammation (i.e. elevation of amniotic fluid cytokines17 and matrix-degrading enzymes18) identified as early as the mid-trimester are at risk for subsequent preterm delivery.

It is notable that the molecular signals for the onset of parturition, whether normal parturition at term or various forms of abnormal parturition, are not well understood. Nonetheless, the mechanisms by which infection leads to labor have been elucidated, at least in part. There is some evidence that normal spontaneous labor at term has features characteristic of inflammatory processes19 but the extent to which the mechanisms of normal and abnormal labors overlap to produce uterine contractions is largely unknown. Furthermore, it is not well understood how risk factors for preterm delivery (such as African ancestry, smoking, cervical shortening and others) impact upon molecular events to increase the likelihood of early labor, though several of these factors have been linked to inflammatory processes.

A similar lack of clarity exists for the phenomenon of rupture of membranes (ROM). While ROM is a feature of most spontaneous labors, its occurrence prior to the onset of labor (known as ‘premature’ – or ‘prelabor’ – rupture of membranes, or PROM) is considered, at least in some contexts, abnormal. When PROM occurs prior to 37 weeks of gestation, it is known as ‘preterm PROM’, or PPROM. PPROM complicates 2–4% of all singleton and 7–20% of twin pregnancies and is associated with 18–20% of perinatal deaths.20 The processes leading to ROM in general, and to PROM/PPROM in particular, are incompletely understood. Again, there is evidence of a role for inflammatory processes with a secondary component of protease activity leading to weakening of the membranes,21 but how all these events are timed or produced in sequence has not been well defined. For the purposes of this review, unless otherwise stated we include both spontaneous preterm labor with intact membranes and PPROM as part of the same spectrum of phenomena leading to early delivery.

Inflammation can be considered a regulated process by which the body responds to injurious stimuli in an attempt to limit the scope of damage and repair affected tissues. One convenient conceptual model for inflammatory responses in pregnancy is that they are part of a maternal self-preservation reaction to threats to the mother, fetus or both. The resultant production of labor is not so much a ‘side-effect’ as a direct and possibly desired consequence: it leads to the evacuation of an infected body cavity that jeopardizes the health and/or the life of the mother, so that reproductive capacity is preserved for the future.

[A]Frequency and clinical significance of intrauterine infection

Intrauterine infections caused by bacteria are considered to be the leading cause of infection-associated preterm labor. The amniotic cavity is normally sterile; <1% of women not in labor at term will have bacteria in the amniotic fluid. Therefore, the isolation of bacteria in the amniotic fluid is a pathologic finding, known as microbial invasion of the amniotic cavity (MIAC). Most such colonization is subclinical and is undetectable without amniotic fluid analysis. The frequency of MIAC depends upon clinical presentation and gestational age. In patients with preterm labor with intact membranes, the rate of positive amniotic fluid cultures is 12.8%.22 However, among those patients who have preterm labor with intact membranes who go on to deliver a preterm neonate, the frequency is nearly double (22%). Among women with PPROM, the rate of positive amniotic fluid cultures at admission is 32.4%; however, by the time labor begins, as many as 75% will have MIAC,22 suggesting that microbial invasion is enhanced by removal of the physical barrier of the membranes after they rupture. The frequency of MIAC among women with cervical insufficiency is as high as 51%.23 If the cervix is short (sonographic cervical length <25 mm, an independent risk factor for preterm birth) MIAC has been noted in 9% of cases.24 All of the above values are likely to be underestimates, given that recent studies have demonstrated the relative inferiority of traditional culturing methodologies compared to polymerase chain reaction for detection of bacterial and viral pathogens.25

Patients with MIAC are more likely to deliver preterm, have spontaneous ROM, develop clinical chorioamnionitis, and experience adverse perinatal outcomes than patients with preterm labor or PPROM with sterile amniotic fluid. The lower the gestational age at presentation (preterm labor with intact membranes or PPROM), the higher the frequency of positive amniotic fluid cultures.26 Thus, infection is more prevalent in earlier spontaneous preterm birth.

As noted above, it is likely that not only infection per se, but also the inflammation that results from infection and, indeed, inflammatory states not due to infection, which is responsible for the phenomena of preterm labor and PROM. This may account for many cases in which there is neither clinical nor microbiological evidence of intrauterine infection, or in which infection occurs in sites remote from the gestational tissues.

[A]The role of viruses in preterm labor

Data related to viruses and preterm birth are relatively scarce, though evidence suggests that viral entry into trophoblast cells induces apoptosis and the resultant inflammatory events can lead to preterm birth.27 Viral DNA is detected in the amniotic fluid of up to 15% of asymptomatic low-risk pregnancies.28 The most common viral DNA isolates, either in low- or high-risk pregnancies, are adenovirus, cytomegalovirus, and enterovirus. The absence of a global marker for viral genomes (paralleling bacterial 16S ribosomal RNA, common to many different bacterial species) limits current molecular methods to screening for specific, known viruses.

Acute intrauterine viral exposure may result in preterm labor and delivery. Pregnant women are at higher risk of spontaneous preterm birth if they have circulating hepatitis B virus antigens.29

Experimental models also suggest the possible induction of labor by viral infection. Polyinosinic:cytidylic acid [poly(I:C)] is a toll-like receptor (TLR)3 ligand and a synthetic analog of double-stranded RNA (a replication intermediate in the life cycle of most viruses). Poly(I:C) induces preterm delivery in mice when injected into the uterus in mid–late gestation30 or systemically in late gestation.31

[A]Molecular mechanisms linking infection and labor

Micro-organisms are recognized by TLRs and other pattern recognition receptors and activate the innate immune system, inducing a proinflammatory cascade orchestrated by, among other elements, the transcription factor NF-κB.32 This cascade results in the elaboration of effector molecules such as cytokines [e.g. interleukin (IL)-1 and tumor necrosis factor (TNF-α)], chemokines (e.g. IL-8),22 prostaglandins,33 proteases and other enzymes,34 to produce a coordinated response featuring uterine contractions, placental detachment, infiltration of inflammatory cells into gestational tissues, a series of biochemical and structural changes in the cervix known as ‘ripening’ and weakening of the fetal membranes (Fig. 1). These cascades may also be activated by mechanisms that are not primarily infectious but are accompanied by inflammatory responses, including activation of complement35,36 and generation of thrombin.34

Figure 1.

Figure 1

Overview of proposed pathways of infectious and non-infectious labor. AP-1, activator protein 1; CCL5, chemokine (C-C motif) ligand 5; dsRNA, double-stranded RNA; IL, interleukin; LMW-HA, low molecular weight hyaluronan; LPS, lipopolysaccharide; LTA, lipoteichoic acid; NFκB, nuclear factor κB; PAF, platelet-activating factor; PGN, peptidoglycan; STAT, signal transducers and activators of transcription; TNF, tumor necrosis factor.

The evidence that the above mechanisms are in play is abundant, and includes both data from humans (associating inflammatory mediators with preterm labor and infection) and experiments performed in animal models (mice,10,11,30 rats,5 rabbit,9 sheep,7,37 non-human primates,8 and other species) in which bacteria,9 bacterial products6,10,3739 or inflammatory cytokines 8,11 induce labor accompanied by the stereotypical expression of inflammatory markers. The clinical use of prostaglandins to induce labor and, conversely, of prostaglandin synthase inhibitors to suppress uterine contractions is well known. The anti-inflammatory cytokine IL-10 has been shown to prevent delivery in a monkey model of bacterially induced preterm labor8 and LPS-induced preterm birth in mice40 and rats.41

Genetic evidence also supports the involvement of TLRs, inflammatory cytokines and proteases in infection/inflammation-associated preterm birth. Genetic polymorphisms for TLR4, TNF-α, IL-1β, interferon (IFN)-γ, IL-6, matrix metalloproteinase (MMP)-1 and MMP-9 have been associated with differential risk of spontaneous preterm birth.4246 Some of these genetic risks appear to be specific for racial groupings or environmental exposures, emphasizing the multifactorial nature of genetic risk and the importance of gene–environment interaction in determining phenotype.45,46

The evidence suggests that molecular cascades leading to preterm delivery may be activated well before preterm labor becomes clinically apparent and may account for the observation that antibiotic therapy is ineffective for treating preterm labor even in cases of overt infection. The search for pre-existing infection and inflammation has extended as far back as the interval prior to conception, though antibiotic treatment trials conducted in the preconception period47 and first-trimester48 have not been effective in impacting the risk of subsequent preterm delivery.

The recent clinical re-discovery of progesterone as an effective agent to prevent preterm birth is also relevant.4951 Data have supported the concept that progesterone’s mechanism of action involves suppression of inflammation52 (see below).

[A]Molecular intermediates of infection- and inflammation-associated preterm labor

[B]Toll-like receptors (TLRs)

Activation of the innate immune system by ‘pathogen-associated molecular patterns’, or PAMPs, is the first step by which micro-organisms are thought to initiate an inflammatory response. TLRs are members of a family of cell-surface proteins responsible for recognition of a diverse spectrum of pathogens and for generating downstream signals coordinating the host immediate (i.e. non-adaptive) response against non-self. TLRs typically dimerize or hetero-dimerize and link to additional proteins (e.g. binding proteins, adaptor proteins, etc.) to exert their effects.

Recognition of PAMPs by TLRs on leukocytes (e.g. monocytes, neutrophils, macrophages)53 and other cells and tissues (such as dendritic cells, epithelial cells and trophoblast54) induces an intracellular signal transduction cascade that leads to the transcription of genes such as inflammatory cytokines, chemokines, interferons, and other effectors (Fig. 1).

Among the presently known 13 TLRs, only TLR1–10 have been found in humans.55 The expression of all 10 TLRs has been described in the human placenta, and the dominant cell type expressing these TLRs is the trophoblast.56 TLRs are differentially expressed by trophoblast according to the gestational age and stage of differentiation. The lack of TLR expression by the outer trophoblast layer suggests that the first- and second-trimester placenta will only respond to a microbe that has broken through this outer layer,57 a possible mechanism for minimizing over-reactions to exposures that do not represent a real threat to the pregnancy. Expression of TLRs across gestation has been demonstrated in the uterus, cervix, and placenta of mice.58

[C]TLR2

TLR2 plays a major role in Gram-positive bacterial recognition.55 TLR2 hetero-dimerizes with either TLR1 or TLR6. These dimers recognize constituents of Gram-positive bacteria such as peptidoglycan (PGN), lipoteichoic acid (LTA), meningococcal porins and molecular patterns associated with fungi, parasites and viruses. Studies in pregnant mice demonstrate that group B streptococcus59 and PGN (extracted from Gram-positive cell walls)6 can induce preterm delivery in a dose-dependent manner.

Women with chorioamnionitis who deliver preterm show significant upregulation of the TLR2 receptor in the fetal membranes, implicating a role for the receptor in preterm birth and infection.60 Systemic administration of PGN induces activation of the NF-κB transcription factor, and first trimester trophoblast cells produce significant amounts of IL-8 and IL-6, ultimately leading to apoptosis after engagement of TLR2.61

[C]TLR3

As noted above, TLR3 is involved in the response to viral infection by recognizing double-stranded RNA.55 Activation of TLR3 via administration of the synthetic analog poly(I:C) induces preterm delivery in the mouse along with the enhanced production of the transcription factor NF-κB, IFN-β and the chemokine (C-C motif) ligand 5 (CCL5) in gestational tissues.6,31

[C]TLR4

TLR4 recognizes lipopolysaccharide (LPS) motifs found in the majority of Gram-negative bacteria. Using TLR4-deficient animals, it has been demonstrated that TLR4 is necessary for normal susceptibility to preterm delivery induced by LPS10 or E. coli.62 TLR4-neutralizing monoclonal antibody significantly reduces the incidence of inflammation-induced preterm delivery and fetal death in mice.63 Pretreatment with TLR4 receptor antagonists inhibits LPS-induced preterm uterine contractility, cytokines and prostaglandins in rhesus monkeys.64 Elevated leukocyte TLR4 levels may be a useful biomarker associated with preterm labor.65

[C]TLR9

TLR9 recognizes unmethylated CpG DNA motifs. Such motifs are present in double-stranded DNA viruses, fetal DNA, and in >80% of bacterial genomes.55 In a study using CpG to activate TLR9 in pregnant mice, IL-10 KO mice were highly susceptible to CpG-mediated inflammatory responses comprised of macrophage and neutrophil migration to the placenta coupled with a marked increase in serum TNF-α and preterm birth.66

[B]Synergy among TLR signaling pathways

TLR2 and TLR4 signaling pathways act in a synergistic fashion with TLR3 pathways.6,67,68 Combined stimulation with TLR2 and TLR3 agonists leads to the induction of preterm delivery and to synergistic expression of both TLR2- and TLR3-dependent proinflammatory mediators both in vivo and in vitro (Fig. 2). This synergy is mediated in part via induction of TLR2 by both TLR2 and TLR3 ligand.6 In a second example of synergy, TLR4 activation by LPS treatment of mice infected with murine gammaherpesvirus-68 induces preterm delivery in 100% of animals in <24 h, but in only 29% of mice without prior viral infection. This synergy leads to upregulation of proinflammatory cytokines and chemokines in placenta and decidua in vivo.67,68

Figure 2.

Figure 2

Synergy between toll-like receptor (TLR)-2 and TLR3 activation. (a) In vivo: preterm delivery rates in day-14.5 pregnant CD-1 mice following intrauterine administration of peptidoglycan (PGN) (TLR2 agonist) and/or polyinosinic:cytidylic acid [poly(I:C)] (TLR3 agonist). Preterm delivery was defined as delivery of at least one pup within 48 h (all deliveries occurred in <36 h). P-Values are by Fisher’s exact test. (b) In vitro: RAW 264.7 cells were stimulated with either phosphate-buffered saline, PGN (1 g/mL), poly(I:C) (10 g/mL) or both PGN and poly(I:C) for 5 h. Real-time polymerase chain reaction was performed for interleukin (IL)-1β and normalized to the housekeeping gene glyceraldehyde 3-phosphate dehydrogenase (GAPDH). P-Value was calculated for all four treatments simultaneously by analysis of variance. n = 3 replicates per condition. Depicted is a representative example from among three repeat experiments. Similar results were obtained for tumor necrosis factor-α, nitric oxid synthase 2 and chemokine (C-C motif) ligand 5 (CCL5) (not shown).6 Modified from Ilievski and Hirsch.6

[B]Cytokines and chemokines

Changes in levels of proinflammatory cytokines and chemokines such as IL-1, IL-6, IL-8, and TNF have all been implicated in the onset and progression of preterm labor in humans.69,70 The association of preterm labor with elevations in the expression of inflammatory cytokines within the amniotic cavity has been cited above. Women with preterm labor and intact membranes who delivered within 7 days of amniocentesis had higher amniotic fluid concentrations of proinflammatory cytokines than those who delivered more than 7 days after amniocentesis regardless of the amniotic fluid culture results.71 Various studies have shown that these and other proinflammatory factors are detectable in cervicovaginal fluid during the course of pregnancy in women with bacterial vaginosis or in those who had preterm delivery with associated intra-amniotic infection.72,73 Moreover, a significant increase in inflammatory cytokines, such as IL-1β, IL-6, IL-8 and TNF-α in cervicovaginal fluid has been shown to be a risk factor for preterm labor and birth.74,75 These studies suggest that these factors may constitute useful predictors of preterm labor.

In experimental animals (mice and non-human primates) administration of IL-1 or TNF-α into the gestational compartment or the peritoneal cavity was sufficient to induce labor and delivery.11,76 The redundancy of cytokine signaling networks has been well established and has led to the conclusion that although sufficient, individual cytokines may not be necessary for preterm labor. Thus, a study using mice lacking receptors for IL-1 and TNF demonstrated that although IL-1 signaling was not required for a normal response to bacterially induced labor, the combination of IL-1 and TNF signaling is necessary.77

[B]Prostaglandins

Primary prostaglandins are formed from arachidonic acid through activity of the cyclooxygenase (COX) enzyme complex, with COX-1 considered a constitutive isoform (though this characterization has not proven accurate) and COX-2 an inducible isoform of the enzyme. Prostaglandins stimulate uterine contractions and cervical ripening during labor. Prostaglandin E2 (PGE2) and prostaglandin F (PGF) are produced by maternal and fetal tissues during parturition, and the concentrations of both increase in the amniotic fluid during labor.33 Administration of prostaglandin synthase inhibitors suppresses uterine activity, while exogenous prostaglandin products are commonly used to induce labor. In one report, both COX-1 and COX-2 expression within the uterus was significantly altered within 2 h of LPS administration, with COX-2 increasing and COX-1 decreasing.78

The NAD1-dependent 15-hydroxy prostaglandin dehydrogenase (PGDH) is responsible for the initial inactivation of prostaglandins, catalyzing the conversion of primary prostaglandins to their biologically inactive 15-keto derivatives. Expression and activity of PGDH have been demonstrated in feto-maternal tissues of different species. Reduced PGDH expression and activity in myometrium and chorion may be important in term and preterm birth in humans.33 In the mouse, PGDH mRNA increased in placentas and fetal membranes.79 during late gestation. PGDH gene is downregulated during bacterially induced preterm labor.62 Thus, the synthesis and degradation of prostaglandins appear to be regulated both in spontaneous and infection-induced labors.

[B]Progesterone

Progesterone has an essential role in maintaining pregnancy primarily by promoting uterine quiescence. In many species the withdrawal of progesterone (e.g. via ovariectomy in rodents or the administration of antiprogestational agents in rodents and humans) leads to labor.

However, the importance of progesterone for maintenance of human pregnancy was for many years obscured by the observation that humans do not experience a drop in circulating progesterone prior to the onset of parturition (unlike some species, such as rodents). Progesterone therapy is an effective intervention for preventing preterm birth in humans with specific risk factors;4951 however, it results in seemingly insignificant alterations of circulating progesterone. This finding and other recent observations have led to the conclusion that a functional, rather than absolute withdrawal of progesterone occurs, possibly within the critical tissues of the cervix or the fetal membranes.50,80 One mechanism for such a functional withdrawal might occur via regulation of the relative expression of agonist and antagonist receptors.81

The mechanism of action of progesterone to prevent delivery may involve its anti-inflammatory properties. Pretreatment with progesterone or medroxyprogesterone acetate in mice injected with intrauterine LPS was associated with suppression of activation of contraction-associated genes and inflammatory mediators, prevention of cervical ripening, reduced expression of TLR2 receptors and a reduction in preterm labor in the mouse.52 Similarly, progesterone pretreatment of placental chorionic plate arteries from term pregnancies was associated with reduced production of IL-6 after LPS exposure.82 Progesterone exerts a negative effect on prostaglandin production.83

[B]Nitric oxide (NO)

Nitric oxide (NO) is a major paracrine mediator and important regulatory agent in various female reproductive processes, including labor and delivery. Throughout gestation, production of NO remains upregulated in myometrium and contributes to uterine quiescence.84 Close to term, NO production decreases. Progesterone is reported to upregulate NO synthase (NOS) II expression and NO production in the uterus.85 A decrease in serum progesterone or administration of low-dose antiprogestins enhances the effectiveness of NO inhibitors, causing preterm labor in the mouse.86

[B]Reactive oxygen species

Reactive oxygen species (ROS) are generated by the body’s response to diverse insults such as infection. Free radicals may activate collagenolytic enzymes and impair fetal membrane integrity.87 Human studies have consistently demonstrated that increased ROS production occurs in preterm infants and is associated with a relative lack of antioxidant enzyme concentration and activity. Urinary 8-hydroxy-20-deoxyguanosine (a sensitive marker of oxidative stress) is significantly higher in preterm compared with term infants.88

[B]Complement

The complement system is activated in response to infection and leads to the release of several biological components, which can induce smooth muscle contraction, enhance vascular permeability and attract white blood cells. Studies using animal models show that excessive complement activation at the feto-maternal interface places the fetus at risk for growth restriction or death and pregnancy loss.35 Complement activation in early pregnancy is associated with preterm delivery.36 Clinical studies report that preterm labor in the context of infection is associated with activation of the complement system.36

[B]Platelet-activating factor (PAF)

Platelet-activating factor (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) is a potent phospholipid inflammatory mediator produced by most cells. Local and systemic release of PAF is tightly regulated by the enzyme phospholipase A2; the enzyme PAF-acetylhydrolase (PAF-AH) mediates its degradation. Mediators of inflammation decrease levels and transcription of PAF-AH. PAF elicits its diverse effects through activation of a G-protein-coupled receptor, PAF receptor.

Cytokines and endotoxin can decrease the release of PAF-AH from uterine decidual cells.89 Systemic levels of PAF-AH decrease, while levels of PAF increase in rats as parturition nears.90 PAF is elevated in the amniotic fluid of patients with preterm labor who ultimately deliver preterm.91 Intrauterine administration of a stable PAF analog (mcPAF) in mice on day 15 of gestation causes preterm delivery.10

[B]The ‘two-hit hypothesis’ and endogenous toll-like receptor ligands in preterm labor

The discovery of synergy during combined stimulation of TLR2 or TLR4 (receptors for Gram-positive and -negative bacteria, respectively) and TLR3 (viral receptor)6,67,68 has led to the development of a ‘two-hit hypothesis’ to explain the pathophysiology of infection-associated preterm labor. As noted above, preterm labor may be viewed as a self-preservation response by the mother, whose health has been jeopardized by an infected bodily compartment. Preterm delivery is an event with dire consequences for the fetus in nature and therefore must have a well-regulated trigger mechanism. A ‘two hit’ trigger and the existence of synergism would tend to blunt the maternal response to mild insults (such as subclinical infection), while providing for rapid and efficient amplification of the labor response in cases of a superimposed more severe infection.

This two-hit postulate might also explain the phenomenon of ‘idiopathic’ preterm labor, or preterm labor for which there is no apparent cause. Several ‘endogenous TLR ligands’ produced by the host have been described. One or more of these endogenous ligands, if expressed at inappropriate levels, times or sites, might constitute the first ‘hit’, with a second hit (normally insufficient to have a deleterious effect) providing a sufficient stimulus to induce labor.

In the context of pregnancy there are several candidates for such a dysregulated endogenous TLR ligand. One of these is surfactant protein (SP)-A, the major lung surfactant protein and a ligand for TLR2 and TLR4. Human myometrial cells express SP-A binding sites and respond to SP-A to initiate signaling events related to human parturition.92 Condon et al. reported that SP-A secreted by the fetal lung serves as an inflammatory signal for parturition,93 causing activation and migration of fetal macrophages to the maternal uterus leading to premature delivery.

A second candidate, endogenous TLR ligand, is a low molecular weight hyaluronic acid (HA).94 HA is a disaccharide glycosaminoglycan polymer (composed of as many as tens of thousands of disaccharide repeats). HA plays an important role in cervical ripening and is involved in the regulation of cervical tissue water content, collagenolytic enzymes and cytokines.95 Low molecular weight degradation products of HA polymers are produced during inflammation and are ligands for TLR2 and TLR4.94

[A]Conclusions

The link between infection and preterm labor has long been recognized. In recent years the mechanisms underlying this phenomenon have become clearer. It may well be that we are nearing a complete picture of the molecular pathways by which infection leads to labor. Important questions remain, however: where is the mechanistic overlap between infectious and non-infectious causes of labor to produce the same end product of uterine contractions and rupture of membranes? Are idiopathic preterm labors the consequence of inappropriate activation of endogenous inflammatory pathways and, if so, can this be corrected? Can diagnostic and predictive methods be improved in order to identify patients at risk before preterm labor becomes clinically apparent, by which time it is in general too late for existing treatments to be effective? The answers to these and other questions may lead to clinical tools to further reduce the incidence, morbidity and mortality of preterm birth, which, despite decades of research, remains a major source of human suffering.

Research directions.

  • Enhance diagnostic and predictive tools in order to improve the identification of patients at risk before preterm labor becomes clinically apparent, by which time it is in general too late for existing treatments to be effective. Such tools might include a molecular signature in serum, cervico-vaginal secretions or amniotic fluid.

  • Improve understanding of the role of genetics, epigenetics and gene–environment interactions in the pathophysiology of preterm labor.

  • Improve therapeutic interventions to treat preterm labor.

  • Elucidate the role of fetus in initiation and perpetuation of preterm labor and delivery.

  • Understand the role of endogenously produced factors in the genesis of abnormal labor.

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

Conflict of interest statement None declared.

Funding sources None.

References

  • 1.Martin JA, Hamilton BE, Sutton PD, et al. Births: final data for 2007. National vital statistics reports: from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System. 2010;58:1–85. [PubMed] [Google Scholar]
  • 2.Lockwood CJ. The diagnosis of preterm labor and the prediction of preterm delivery. Clin Obstet Gynecol. 1995;38:675–87. doi: 10.1097/00003081-199538040-00002. [DOI] [PubMed] [Google Scholar]
  • 3.Lamont RF. Infection in the prediction and antibiotics in the prevention of spontaneous preterm labour and preterm birth. BJOG. 2003;110(Suppl 20):71–5. doi: 10.1016/s1470-0328(03)00034-x. [DOI] [PubMed] [Google Scholar]
  • 4.Romero R, Sirtori M, Oyarzun E, et al. Prevalence, microbiology, and clinical significance of intraamniotic infection in women with preterm labor and intact membranes. Infect Labor. 1981;161:817–24. doi: 10.1016/0002-9378(89)90409-2. [DOI] [PubMed] [Google Scholar]
  • 5.Bennett WA, Terrone DA, Rinehart BK, Kassab S, Martin JN, Jr, Granger JP. Intrauterine endotoxin infusion in rat pregnancy induces preterm delivery and increases placental prostaglandin F2alpha metabolite levels. Am J Obstet Gynecol. 2000;182:1496–1501. doi: 10.1067/mob.2000.106848. [DOI] [PubMed] [Google Scholar]
  • 6.Ilievski V, Hirsch E. Synergy between viral and bacterial toll-like receptors leads to amplification of inflammatory responses and preterm labor in the mouse. Biol Reprod. 2010;83:767–73. doi: 10.1095/biolreprod.110.085464. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Schlafer DH, Yuh B, Foley GL, Elssaser TH, Sadowsky D, Nathanielsz PW. Effect of Salmonella endotoxin administered to the pregnant sheep at 133–142 days gestation on fetal oxygenation, maternal and fetal adrenocorticotropic hormone and cortisol, and maternal plasma tumor necrosis factor alpha concentrations. Biol Reprod. 1994;50:1297–1302. doi: 10.1095/biolreprod50.6.1297. [DOI] [PubMed] [Google Scholar]
  • 8.Sadowsky DW, Novy MJ, Witkin SS, Gravett MG. Dexamethasone or interleukin-10 blocks interleukin-1beta-induced uterine contractions in pregnant rhesus monkeys. Am J Obstet Gynecol. 2003;188:252–63. doi: 10.1067/mob.2003.70. [DOI] [PubMed] [Google Scholar]
  • 9.Davies JK, Shikes RH, Sze CI, et al. Histologic inflammation in the maternal and fetal compartments in a rabbit model of acute intra-amniotic infection. Am J Obstet Gynecol. 2000;183:1088–93. doi: 10.1067/mob.2000.108888. [DOI] [PubMed] [Google Scholar]
  • 10.Elovitz MA, Wang Z, Chien EK, Rychlik DF, Phillippe M. A new model for inflammation-induced preterm birth: the role of platelet-activating factor and Toll-like receptor-4. Am J Pathol. 2003;163:2103–11. doi: 10.1016/S0002-9440(10)63567-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Romero R, Mazor M, Tartakovsky B. Systemic administration of interleukin-1 induces preterm parturition in mice. Am J Obstet Gynecol. 1991;165:969–71. doi: 10.1016/0002-9378(91)90450-6. [DOI] [PubMed] [Google Scholar]
  • 12.Fan YD, Pastorek JG, 2nd, Miller JM, Jr, Mulvey J. Acute pyelonephritis in pregnancy. Am J Perinatol. 1987;4:324–6. doi: 10.1055/s-2007-999800. [DOI] [PubMed] [Google Scholar]
  • 13.Benedetti TJ, Valle R, Ledger WJ. Antepartum pneumonia in pregnancy. Am J Obstet Gynecol. 1982;144:413–17. doi: 10.1016/0002-9378(82)90246-0. [DOI] [PubMed] [Google Scholar]
  • 14.Xiong X, Buekens P, Fraser WD, Beck J, Offenbacher S. Periodontal disease and adverse pregnancy outcomes: a systematic review. BJOG. 2006;113:135–43. doi: 10.1111/j.1471-0528.2005.00827.x. [DOI] [PubMed] [Google Scholar]
  • 15.Gomez R, Ghezzi F, Romero R, Munoz H, Tolosa JE, Rojas I. Premature labor and intra-amniotic infection. Clinical aspects and role of the cytokines in diagnosis and pathophysiology. Clin Perinatol. 1995;22:281–42. [PubMed] [Google Scholar]
  • 16.Gray DJ, Robinson HB, Malone J, Thomson RB., Jr Adverse outcome in pregnancy following amniotic fluid isolation of Ureaplasma urealyticum. Prenat Diagn. 1992;12:111–17. doi: 10.1002/pd.1970120206. [DOI] [PubMed] [Google Scholar]
  • 17.Wenstrom KD, Andrews WW, Hauth JC, Goldenberg RL, DuBard MB, Cliver SP. Elevated second-trimester amniotic fluid interleukin-6 levels predict preterm delivery. Am J Obstet Gynecol. 1998;178:546–50. doi: 10.1016/s0002-9378(98)70436-3. [DOI] [PubMed] [Google Scholar]
  • 18.Yoon BH, Oh SY, Romero R, et al. An elevated amniotic fluid matrix metalloproteinase-8 level at the time of mid-trimester genetic amniocentesis is a risk factor for spontaneous preterm delivery. Am J Obstet Gynecol. 2001;185:1162–7. doi: 10.1067/mob.2001.117678. [DOI] [PubMed] [Google Scholar]
  • 19.Dudley DJ, Collmer D, Mitchell MD, Trautman MS. Inflammatory cytokine mRNA in human gestational tissues: implications for term and preterm labor. J Soc Gynecol Invest. 1996;3:328–35. [PubMed] [Google Scholar]
  • 20.Caughey AB, Robinson JN, Norwitz ER. Contemporary diagnosis and management of preterm premature rupture of membranes. Rev Obstet Gynecol. 2008;1:11–22. [PMC free article] [PubMed] [Google Scholar]
  • 21.Kumar D, Fung W, Moore RM, et al. Proinflammatory cytokines found in amniotic fluid induce collagen remodeling, apoptosis, and biophysical weakening of cultured human fetal membranes. Biol Reprod. 2006;74:29–34. doi: 10.1095/biolreprod.105.045328. [DOI] [PubMed] [Google Scholar]
  • 22.Romero R, Espinoza J, Goncalves LF, Kusanovic JP, Friel L, Hassan S. The role of inflammation and infection in preterm birth. Semin Reprod Med. 2007;25:21–39. doi: 10.1055/s-2006-956773. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Romero R, Gonzalez R, Sepulveda W, et al. Infection and labor. VIII. Microbial invasion of the amniotic cavity in patients with suspected cervical incompetence: prevalence and clinical significance. Am J Obstet Gynecol. 1992;167:1086–91. doi: 10.1016/s0002-9378(12)80043-3. [DOI] [PubMed] [Google Scholar]
  • 24.Hassan S, Romero R, Hendler I, et al. A sonographic short cervix as the only clinical manifestation of intra-amniotic infection. J Perinat Med. 2006;34:13–19. doi: 10.1515/JPM.2006.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.DiGiulio DB, Romero R, Amogan HP, et al. Microbial prevalence, diversity and abundance in amniotic fluid during preterm labor: a molecular and culture-based investigation. PloS One. 2008;3:e3056. doi: 10.1371/journal.pone.0003056. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Romero R, Mazor M, Morrotti R, et al. Microbial invasion of the amniotic cavity in spontaneous rupture of membranes at term. Infect Labor. 1992;166:129–33. doi: 10.1016/0002-9378(92)91845-2. [DOI] [PubMed] [Google Scholar]
  • 27.Koi H, Zhang J, Parry S. The mechanisms of placental viral infection. Ann NY Acad Sci. 2001;943:148–56. doi: 10.1111/j.1749-6632.2001.tb03798.x. [DOI] [PubMed] [Google Scholar]
  • 28.Baschat AA, Towbin J, Bowles NE, Harman CR, Weiner CP. Prevalence of viral DNA in amniotic fluid of low-risk pregnancies in the second trimester. J Maternal–Fetal Neonat Med. 2003;13:381–4. doi: 10.1080/jmf.13.6.381.384. [DOI] [PubMed] [Google Scholar]
  • 29.Reddick KLB, Jhaveri R, Gandhi M, James AH, Swamy GK. Pregnancy outcomes associated with viral hepatitis. J Viral Hepatitis. 2011;18:e394–8. doi: 10.1111/j.1365-2893.2011.01436.x. [DOI] [PubMed] [Google Scholar]
  • 30.Ilievski V, Lu SJ, Hirsch E. Activation of toll-like receptors 2 or 3 and preterm delivery in the mouse. Reprod Sci. 2007;14:315–20. doi: 10.1177/1933719107302959. [DOI] [PubMed] [Google Scholar]
  • 31.Koga K, Cardenas I, Aldo P, et al. Activation of TLR3 in the trophoblast is associated with preterm delivery. Am J Reprod Immunol. 2009;61:196–212. doi: 10.1111/j.1600-0897.2008.00682.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Lee Y, Allport V, Sykes A, Lindstrom T, Slater D, Bennett P. The effects of labour and of interleukin 1 beta upon the expression of nuclear factor kappa B related proteins in human amnion. Mol Hum Reprod. 2003;9:213–18. doi: 10.1093/molehr/gag026. [DOI] [PubMed] [Google Scholar]
  • 33.Patel FA, Challis JR. Prostaglandins and uterine activity. Front Horm Res. 2001;27:31–56. doi: 10.1159/000061040. [DOI] [PubMed] [Google Scholar]
  • 34.Phillippe M, Elovitz M, Saunders T. Thrombin-stimulated uterine contractions in the pregnant and nonpregnant rat. J Soc Gynecol Invest. 2001;8:260–5. doi: 10.1016/s1071-5576(01)00121-6. [DOI] [PubMed] [Google Scholar]
  • 35.Girardi G, Bulla R, Salmon JE, Tedesco F. The complement system in the pathophysiology of pregnancy. Mol Immunol. 2006;43:68–77. doi: 10.1016/j.molimm.2005.06.017. [DOI] [PubMed] [Google Scholar]
  • 36.Lynch AM, Gibbs RS, Murphy JR, Giclas PC, Salmon JE, Holers VM. Early elevations of the complement activation fragment C3a and adverse pregnancy outcomes. Obstet Gynecol. 2011;117:75–83. doi: 10.1097/AOG.0b013e3181fc3afa. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Grigsby PL, Hirst JJ, Scheerlinck JP, Phillips DJ, Jenkin G. Fetal responses to maternal and intra-amniotic lipopolysaccharide administration in sheep. Biol Reprod. 2003;68:1695–1702. doi: 10.1095/biolreprod.102.009688. [DOI] [PubMed] [Google Scholar]
  • 38.Dudley DJ, Chen CL, Branch DW, Hammond E, Mitchell MD. A murine model of preterm labor: inflammatory mediators regulate the production of prostaglandin E2 and interleukin-6 by murine decidua. Biol Reprod. 1993;48:33–9. doi: 10.1095/biolreprod48.1.33. [DOI] [PubMed] [Google Scholar]
  • 39.Fidel PL, Jr, Romero R, Wolf N, et al. Systemic and local cytokine profiles in endotoxin-induced preterm parturition in mice. Am J Obstet Gynecol. 1994;170:1467–75. doi: 10.1016/s0002-9378(94)70180-6. [DOI] [PubMed] [Google Scholar]
  • 40.Robertson SA, Skinner RJ, Care AS. Essential role for IL-10 in resistance to lipopolysaccharide-induced preterm labor in mice. J Immunol. 2006;177:4888–96. doi: 10.4049/jimmunol.177.7.4888. [DOI] [PubMed] [Google Scholar]
  • 41.Terrone DA, Rinehart BK, Granger JP, Barrilleaux PS, Martin JN, Jr, Bennett WA. Interleukin-10 administration and bacterial endotoxin-induced preterm birth in a rat model. Obstet Gynecol. 2001;98:476–80. doi: 10.1016/s0029-7844(01)01424-7. [DOI] [PubMed] [Google Scholar]
  • 42.Moura E, Mattar R, de Souza E, Torloni MR, Gonçalves-Primo A, Daher S. Inflammatory cytokine gene polymorphisms and spontaneous preterm birth. J Reprod Immunol. 2009;80:115–21. doi: 10.1016/j.jri.2008.11.007. [DOI] [PubMed] [Google Scholar]
  • 43.Lorenz E, Hallman M, Marttila R, Haataja R, Schwartz DA. Association between the Asp299Gly polymorphisms in the Toll-like receptor 4 and premature births in the Finnish population. Pediatr Res. 2002;52:373–6. doi: 10.1203/00006450-200209000-00011. [DOI] [PubMed] [Google Scholar]
  • 44.Hollegaard MV, Grove J, Thorsen P, et al. Polymorphisms in the tumor necrosis factor alpha and interleukin 1-beta promoters with possible gene regulatory functions increase the risk of preterm birth. Acta Obstet Gynecol Scand. 2008;87:1285–90. doi: 10.1080/00016340802468340. [DOI] [PubMed] [Google Scholar]
  • 45.Ferrand PE, Parry S, Sammel M, et al. A polymorphism in the matrix metalloproteinase-9 promoter is associated with increased risk of preterm premature rupture of membranes in African Americans. Mol Hum Reprod. 2002;8:494–501. doi: 10.1093/molehr/8.5.494. [DOI] [PubMed] [Google Scholar]
  • 46.Fujimoto T, Parry S, Urbanek M, et al. A single nucleotide polymorphism in the matrix metalloproteinase-1 (MMP-1) promoter influences amnion cell MMP-1 expression and risk for preterm premature rupture of the fetal membranes. J Biol Chem. 2002;277:6296–302. doi: 10.1074/jbc.M107865200. [DOI] [PubMed] [Google Scholar]
  • 47.Espinoza J, Erez O, Romero R. Preconceptional antibiotic treatment to prevent preterm birth in women with a previous preterm delivery. Am J Obstet Gynecol. 2006;194:630–7. doi: 10.1016/j.ajog.2005.11.050. [DOI] [PubMed] [Google Scholar]
  • 48.van den Broek NR, White SA, Goodall M, et al. The APPLe study: a randomized, community-based, placebo-controlled trial of azithromycin for the prevention of preterm birth, with meta-analysis. PLoS Med. 2009;6:e1000191. doi: 10.1371/journal.pmed.1000191. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.da Fonseca EB, Bittar RE, Carvalho MH, Zugaib M. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study. Am J Obstet Gynecol. 2003;188:419–24. doi: 10.1067/mob.2003.41. [DOI] [PubMed] [Google Scholar]
  • 50.Hassan SS, Romero R, Vidyadhari D, et al. Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol. 2011;38:18–31. doi: 10.1002/uog.9017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Meis PJ, Klebanoff M, Thom E, et al. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med. 2003;348:2379–85. doi: 10.1056/NEJMoa035140. [DOI] [PubMed] [Google Scholar]
  • 52.Elovitz M, Wang Z. Medroxyprogesterone acetate, but not progesterone, protects against inflammation-induced parturition and intrauterine fetal demise. Am J Obstet Gynecol. 2004;190:693–701. doi: 10.1016/j.ajog.2003.10.693. [DOI] [PubMed] [Google Scholar]
  • 53.Zarember KA, Godowski PJ. Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J Immunol. 2002;168:554–61. doi: 10.4049/jimmunol.168.2.554. [DOI] [PubMed] [Google Scholar]
  • 54.Holmlund U, Cebers G, Dahlfors AR, et al. Expression and regulation of the pattern recognition receptors Toll-like receptor-2 and Toll-like receptor-4 in the human placenta. Immunol. 2002;107:145–51. doi: 10.1046/j.1365-2567.2002.01491.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nature Immunol. 2010;11:373–84. doi: 10.1038/ni.1863. [DOI] [PubMed] [Google Scholar]
  • 56.Mor G. Inflammation and pregnancy: the role of toll-like receptors in trophoblast-immune interaction. Ann NY Acad Sci. 2008;1127:121–8. doi: 10.1196/annals.1434.006. [DOI] [PubMed] [Google Scholar]
  • 57.Mor G, Romero R, Aldo PB, Abrahams VM. Is the trophoblast an immune regulator? The role of Toll-like receptors during pregnancy. Crit Rev Immunol. 2005;25:375–88. doi: 10.1615/critrevimmunol.v25.i5.30. [DOI] [PubMed] [Google Scholar]
  • 58.Gonzalez JM, Xu H, Ofori E, Elovitz MA. Toll-like receptors in the uterus, cervix, and placenta: is pregnancy an immunosuppressed state? Am J Obstet Gynecol. 2007;197:296, e291–296. doi: 10.1016/j.ajog.2007.06.021. [DOI] [PubMed] [Google Scholar]
  • 59.Equils O, Moffatt-Blue C, Ishikawa TO, Simmons CF, Ilievski V, Hirsch E. Pretreatment with pancaspase inhibitor (Z-VAD-FMK) delays but does not prevent intraperitoneal heat-killed group B Streptococcus-induced preterm delivery in a pregnant mouse model. Infect Dis Obstet Gynecol. 2009;2009:749432. doi: 10.1155/2009/749432. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Kim YM, Romero R, Chaiworapongsa T, et al. Toll-like receptor-2 and -4 in the chorioamniotic membranes in spontaneous labor at term and in preterm parturition that are associated with chorioamnionitis. Am J Obstet Gynecol. 2004;191:1346–55. doi: 10.1016/j.ajog.2004.07.009. [DOI] [PubMed] [Google Scholar]
  • 61.Abrahams VM, Aldo PB, Murphy SP, et al. TLR6 modulates first trimester trophoblast responses to peptidoglycan. J Immunol. 2008;180:6035–43. doi: 10.4049/jimmunol.180.9.6035. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Wang H, Hirsch E. Bacterially-induced preterm labor and regulation of prostaglandin-metabolizing enzyme expression in mice: the role of toll-like receptor 4. Biol Reprod. 2003;69:1957–63. doi: 10.1095/biolreprod.103.019620. [DOI] [PubMed] [Google Scholar]
  • 63.Li L, Kang J, Lei W. Role of Toll-like receptor 4 in inflammation-induced preterm delivery. Mol Hum Reprod. 2010;16:267–72. doi: 10.1093/molehr/gap106. [DOI] [PubMed] [Google Scholar]
  • 64.Waldorf KM Adams, Persing D, Novy MJ, Sadowsky DW, Gravett MG. Pretreatment with Toll-like receptor 4 antagonist inhibits lipopolysaccharide-induced preterm uterine contractility, cytokines, and prostaglandins in rhesus monkeys. Reprod Sci. 2008;15:121–27. doi: 10.1177/1933719107310992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Pawelczyk E, Nowicki BJ, Izban MG, et al. Spontaneous preterm labor is associated with an increase in the proinflammatory signal transducer TLR4 receptor on maternal blood monocytes. BMC Pregn Bhildbirth. 2010;10:66. doi: 10.1186/1471-2393-10-66. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Thaxton JE, Romero R, Sharma S. TLR9 activation coupled to IL-10 deficiency induces adverse pregnancy outcomes. J Immunol. 2009;183:1144–54. doi: 10.4049/jimmunol.0900788. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Cardenas I, Means RE, Aldo P, et al. Viral infection of the placenta leads to fetal inflammation and sensitization to bacterial products predisposing to preterm labor. J Immunol. 2010;185:1248–57. doi: 10.4049/jimmunol.1000289. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Cardenas I, Mor G, Aldo P, et al. Placental viral infection sensitizes to endotoxin-induced pre-term labor: a double hit hypothesis. Am J Reprod Immunol. 2011;65:110–17. doi: 10.1111/j.1600-0897.2010.00908.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Farina L, Winkelman C. A review of the role of proinflammatory cytokines in labor and noninfectious preterm labor. Biol Res Nurs. 2005;6:230–8. doi: 10.1177/1099800404271900. [DOI] [PubMed] [Google Scholar]
  • 70.Menon R, Fortunato SJ. Fetal membrane inflammatory cytokines: a switching mechanism between the preterm premature rupture of the membranes and preterm labor pathways. J Perinat Med. 2004;32:391–9. doi: 10.1515/JPM.2004.134. [DOI] [PubMed] [Google Scholar]
  • 71.Figueroa R, Garry D, Elimian A, Patel K, Sehgal PB, Tejani N. Evaluation of amniotic fluid cytokines in preterm labor and intact membranes. J Maternal–Fetal Neonat Med. 2005;18:241–7. doi: 10.1080/13506120500223241. [DOI] [PubMed] [Google Scholar]
  • 72.Mattsby-Baltzer I, Platz-Christensen JJ, Hosseini N, Rosen P. IL-1beta, IL-6, TNFalpha, fetal fibronectin, and endotoxin in the lower genital tract of pregnant women with bacterial vaginosis. Acta Obstet Gynecol Scand. 1998;77:701–6. [PubMed] [Google Scholar]
  • 73.Rizzo G, Capponi A, Rinaldo D, Tedeschi D, Arduini D, Romanini C. Interleukin-6 concentrations in cervical secretions identify microbial invasion of the amniotic cavity in patients with preterm labor and intact membranes. Am J Obstet Gynecol. 1996;175:812–17. doi: 10.1016/s0002-9378(96)80004-4. [DOI] [PubMed] [Google Scholar]
  • 74.Tanaka Y, Narahara H, Takai N, Yoshimatsu J, Anai T, Miyakawa I. Interleukin-1beta and interleukin-8 in cervicovaginal fluid during pregnancy. Am J Obstet Gynecol. 1998;179:644–9. doi: 10.1016/s0002-9378(98)70058-4. [DOI] [PubMed] [Google Scholar]
  • 75.Jun JK, Yoon BH, Romero R, et al. Interleukin 6 determinations in cervical fluid have diagnostic and prognostic value in preterm premature rupture of membranes. Am J Obstet Gynecol. 2000;183:868–73. doi: 10.1067/mob.2000.109034. [DOI] [PubMed] [Google Scholar]
  • 76.Sadowsky DW, Adams KM, Gravett MG, Witkin SS, Novy MJ. Preterm labor is induced by intraamniotic infusions of interleukin-1beta and tumor necrosis factor-alpha but not by interleukin-6 or interleukin-8 in a nonhuman primate model. Am J Obstet Gynecol. 2006;195:1578–89. doi: 10.1016/j.ajog.2006.06.072. [DOI] [PubMed] [Google Scholar]
  • 77.Hirsch E, Filipovich Y, Mahendroo M. Signaling via the type I IL-1 and TNF receptors is necessary for bacterially induced preterm labor in a murine model. Am J Obstet Gynecol. 2006;194:1334–40. doi: 10.1016/j.ajog.2005.11.004. [DOI] [PubMed] [Google Scholar]
  • 78.Gross G, Imamura T, Vogt SK, et al. Inhibition of cyclooxygenase-2 prevents inflammation-mediated preterm labor in the mouse. Am J Physiol Regul Integrat Comp Physiol. 2000;278:R1415–23. doi: 10.1152/ajpregu.2000.278.6.R1415. [DOI] [PubMed] [Google Scholar]
  • 79.Sato TA, Gupta DK, Keelan JA, Marvin KW, Mitchell MD. Cytosolic phospholipase A(2)and 15-hydroxyprostaglandin dehydrogenase mRNA expression in murine uterine and gestational tissues during late pregnancy. Prostagl Leukotr Essent Fatty Acids. 2001;64:247–51. doi: 10.1054/plef.2001.0267. [DOI] [PubMed] [Google Scholar]
  • 80.Luo G, Abrahams VM, Tadesse S, et al. Progesterone inhibits basal and TNF-alpha-induced apoptosis in fetal membranes: a novel mechanism to explain progesterone-mediated prevention of preterm birth. Reprod Sci. 2010;17:532–9. doi: 10.1177/1933719110363618. [DOI] [PubMed] [Google Scholar]
  • 81.Fang X, Wong S, Mitchell BF. Messenger RNA for progesterone receptor isoforms in the late-gestation rat uterus. Am J Physiol. 2002;283:E1167–72. doi: 10.1152/ajpendo.00116.2002. [DOI] [PubMed] [Google Scholar]
  • 82.Shields AD, Wright J, Paonessa DJ, et al. Progesterone modulation of inflammatory cytokine production in a fetoplacental artery explant model. Am J Obstet Gynecol. 2005;193:1144–8. doi: 10.1016/j.ajog.2005.05.046. [DOI] [PubMed] [Google Scholar]
  • 83.Challis JR, Sloboda DM, Alfaidy N. Prostaglandins and mechanisms of preterm birth. Reproduction. 2002;124:1–17. doi: 10.1530/rep.0.1240001. [DOI] [PubMed] [Google Scholar]
  • 84.Yallampalli C, Dong YL, Gangula PR, Fang L. Role and regulation of nitric oxide in the uterus during pregnancy and parturition. J Soc Gynecol Invest. 1998;5:58–67. doi: 10.1016/S1071-5576(97)00106-8. [DOI] [PubMed] [Google Scholar]
  • 85.Goncalves LF, Chaiworapongsa T, Romero R. Intrauterine infection and prematurity. Mental Retard Dev Disabil Res Rev. 2002;8:3–13. doi: 10.1002/mrdd.10008. [DOI] [PubMed] [Google Scholar]
  • 86.Tiboni G, Del Corso A, Marotta RK. Progestational agents prevent preterm birth induced by a nitric oxide synthesis inhibitor in the mouse. In Vivo. 2008;22:447–50. [PubMed] [Google Scholar]
  • 87.Woods JR, Jr, Plessinger MA, Miller RK. Vitamins C and E: missing links in preventing preterm premature rupture of membranes? Am J Obstet Gynecol. 2001;185:5–10. doi: 10.1067/mob.2001.115868. [DOI] [PubMed] [Google Scholar]
  • 88.Nassi N, Ponziani V, Becatti M, Galvan P, Donzelli G. Anti-oxidant enzymes and related elements in term and preterm newborns. Pediatr Int. 2009;51:183–7. doi: 10.1111/j.1442-200X.2008.02662.x. [DOI] [PubMed] [Google Scholar]
  • 89.Kawano Y, Narahara H, Johnston JM. Inhibitory effect of interleukin-8 on the secretion of platelet-activating factor acetylhydrolase by human decidual macrophages. J Soc Gynecol Invest. 1999;6:328–32. doi: 10.1016/s1071-5576(99)00036-2. [DOI] [PubMed] [Google Scholar]
  • 90.Matsubara T, Yasuda K, Johnston JM, et al. Platelet-activating factor (PAF) and PAF acetylhydrolase activity in rat uterus and placenta during the late stages of pregnancy. Biol Reprod. 1997;56:885–90. doi: 10.1095/biolreprod56.4.885. [DOI] [PubMed] [Google Scholar]
  • 91.Silver RK, Caplan MS, Kelly AM. Amniotic fluid platelet-activating factor (PAF) is elevated in patients with tocolytic failure and preterm delivery. Prostaglandins. 1992;43:181–7. doi: 10.1016/0090-6980(92)90085-8. [DOI] [PubMed] [Google Scholar]
  • 92.Garcia-Verdugo I, Tanfin Z, Dallot E, Leroy MJ, Breuiller-Fouche M. Surfactant protein A signaling pathways in human uterine smooth muscle cells. Biol Reprod. 2008;79:348–55. doi: 10.1095/biolreprod.108.068338. [DOI] [PubMed] [Google Scholar]
  • 93.Condon JC, Jeyasuria P, Faust JM, Mendelson CR. Surfactant protein secreted by the maturing mouse fetal lung acts as a hormone that signals the initiation of parturition. Proc Natl Acad Sci USA. 2004;101:4978–83. doi: 10.1073/pnas.0401124101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 94.Jiang D, Liang J, Fan J, et al. Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nature Med. 2005;11:1173–9. doi: 10.1038/nm1315. [DOI] [PubMed] [Google Scholar]
  • 95.El Maradny E, Kanayama N, Kobayashi H, et al. The role of hyaluronic acid as a mediator and regulator of cervical ripening. Hum Reprod. 1997;12:1080–8. doi: 10.1093/humrep/12.5.1080. [DOI] [PubMed] [Google Scholar]

RESOURCES